Pulmonary Hypertension

PAH: eGFR Changes May Predict Survival, Hospitalizations

PAH: eGFR Changes May Predict Survival, Hospitalizations

By

A decrease in baseline estimated glomerular filtration rate in PAH may be a predictor of hospitalization and mortality.

Intermediate-Risk Pulmonary Emboli: Catheter-Directed vs Systemic Thrombolysis

Intermediate-Risk Pulmonary Emboli: Catheter-Directed vs Systemic Thrombolysis

By

Catheter-directed thrombolysis vs systemic thrombolysis strategies show different risk outcomes for patients with intermediate-risk pulmonary embolism.

Pediatric Pulmonary Embolism: 9 Predictors Identified

Pediatric Pulmonary Embolism: 9 Predictors Identified

By

Several clinical predictors of pediatric pulmonary embolism have been identified.

Oral Riociguat May Have Clinical Utility in Severe Pediatric Pulmonary Arterial Hypertension

Oral Riociguat May Have Clinical Utility in Severe Pediatric Pulmonary Arterial Hypertension

By

Use of riociguat may be considered for severe pulmonary arterial hypertension in pediatric patients.

Lung Transplantation in Pulmonary Arterial Hypertension: An Overview

Lung Transplantation in Pulmonary Arterial Hypertension: An Overview

By

Evaluating diagnosis and treatment options for pulmonary arterial hypertension.

Balloon Pulmonary Angioplasty Improves Hemodynamics in CTEPH

Balloon Pulmonary Angioplasty Improves Hemodynamics in CTEPH

By

Balloon pulmonary angioplasty may improve hemodynamics in patients with CTEPH.

Worsening Shortness of Breath in a 40-Year-Old Woman: A Case Study

Worsening Shortness of Breath in a 40-Year-Old Woman: A Case Study

By

A 40-year-old woman presents with worsening shortness of breath after being treated with long-acting nifedipine for 2 years.

Pulmonary Arterial Hypertension: Mechanisms of Exercise Intolerance

Pulmonary Arterial Hypertension: Mechanisms of Exercise Intolerance

By

Exercise intolerance is a hallmark symptom of pulmonary arterial hypertension.

Impaired Cerebral Pressure-Flow Link in Pulmonary Arterial Hypertension

Impaired Cerebral Pressure-Flow Link in Pulmonary Arterial Hypertension

By

Patients with pulmonary arterial hypertension may have an impaired cerebral pressure-flow relationship.

Improving Pulmonary Arterial Compliance in PAH: Riociguat vs PDE5 Inhibitors

Improving Pulmonary Arterial Compliance in PAH: Riociguat vs PDE5 Inhibitors

By

Switching from a phosphodiesterase type 5 inhibitor to riociguat significantly improves pulmonary arterial compliance in patients with PAH.

Pulmonary Artery Compliance Predictive of Mortality in PAH With Adult CHD

Pulmonary Artery Compliance Predictive of Mortality in PAH With Adult CHD

By

Pulmonary artery compliance may be an independent predictor of survival and prognosis in patients with pulmonary artery hypertension associated with congenital heart disease.

Diagnostic Value of Bronchoalveolar Lavage in Idiopathic Pulmonary Fibrosis

Diagnostic Value of Bronchoalveolar Lavage in Idiopathic Pulmonary Fibrosis

By

The diagnostic value of bronchoalveolar lavage in idiopathic pulmonary fibrosis is evaluated.

Methamphetamine-Associated PAH Worse Than Idiopathic PAH

Methamphetamine-Associated PAH Worse Than Idiopathic PAH

By

Pulmonary arterial hypertension associated with the use of methamphetamine is a severe, progressive form of the disease.

Echocardiographic Evaluation Recommended for Hereditary Hemorrhagic Telangiectasia

Echocardiographic Evaluation Recommended for Hereditary Hemorrhagic Telangiectasia

By

Patients with hereditary hemorrhagic telangiectasia may develop pulmonary hypertension.

Chronic Thromboembolic Pulmonary Hypertension, PAH Linked to Depression

Chronic Thromboembolic Pulmonary Hypertension, PAH Linked to Depression

By

Patients with chronic thromboembolic pulmonary hypertension may have higher rates of depression compared to patients with PAH.

Prognostic Value of CT Signs of Pulmonary Veno-occlusive Disease

Prognostic Value of CT Signs of Pulmonary Veno-occlusive Disease

By

Having at least 2 features of pulmonary veno-occlusive disease is linked to reduced survival rate in patients with SSc and PAH.

Borderline Pulmonary Hypertension Commonly Found During Right Heart Catheterization

Borderline Pulmonary Hypertension Commonly Found During Right Heart Catheterization

Borderline pulmonary hypertension is associated with increased risk of mortality in patients undergoing right heart catheterization.

Chronic Thromboembolic PH Diagnosis and Management Update: Expert Q&A

Chronic Thromboembolic PH Diagnosis and Management Update: Expert Q&A

By

Development of CTEPH is associated with traditional thrombotic risk factors, including thrombophilias and inflammatory processes.

Pulmonary Arterial Hypertension: Treatment Tailored by Race and Ethnicity

Pulmonary Arterial Hypertension: Treatment Tailored by Race and Ethnicity

By

Future clinical trials on pulmonary arterial hypertension should include patients from diverse racial and ethnic backgrounds.

Use of 6-Minute Walk Test in Idiopathic Pulmonary Fibrosis

Use of 6-Minute Walk Test in Idiopathic Pulmonary Fibrosis

Guidelines are needed for use of the six-minute walk test in patients with idiopathic pulmonary fibrosis.

Right Ventricular Morphology Predicts Type of Pulmonary Hypertension

Right Ventricular Morphology Predicts Type of Pulmonary Hypertension

By

Right ventricular base/apex ratio during systole can discriminate between types of pulmonary hypertension.

Anxiety and Depression Affect Quality of Life in Idiopathic Pulmonary Fibrosis

Anxiety and Depression Affect Quality of Life in Idiopathic Pulmonary Fibrosis

Quality of life in patients with idiopathic pulmonary fibrosis can be significantly affected by depression and anxiety.

RHC Parameters Useful in Predicting Pulmonary Hypertension Outcomes

RHC Parameters Useful in Predicting Pulmonary Hypertension Outcomes

By

The ratio of hemodynamic markers derived from right heart catheterization can predict treatment outcomes in patients with pulmonary hypertension.

Sarcoidosis-Associated Pulmonary Hypertension: Predicting Factors for Reduced 6MWD

Sarcoidosis-Associated Pulmonary Hypertension: Predicting Factors for Reduced 6MWD

By

Multiple factors have influenced a 6-minute reduction in sarcoidosis-associated pulmonary hypertension.

Case Study: Worsening Leg Edema And Shortness Of Breath In Urgent Care

A man presents to an urgent care clinic with gradually progressive leg edema and shortness of breath.

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Treatments

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Treatments

By

Initial combination therapy with ambrisentan and tadalafil reduced the risk for first clinical failure event in patients with connective tissue disease-associated pulmonary arterial hypertension.

New Metabolites Associated With Hemodynamic Indicators of Right Ventricular-Pulmonary Vascular Dysfunction Discovered

New Metabolites Associated With Hemodynamic Indicators of Right Ventricular-Pulmonary Vascular Dysfunction Discovered

By

Researchers discovered 21 new metabolites associated with 2 or more hemodynamic indicators of right ventricular-pulmonary vascular function.

Exercise Improves Quality of Life in Pulmonary Hypertension

Exercise Improves Quality of Life in Pulmonary Hypertension

By

Researchers analyze the efficacy and safety of exercise training in pulmonary hypertension.

Sign Up for Free e-Newsletters